Rates of osteoporosis screening and treatment are low in patients with recent stroke despite elevated risk for low-trauma fracture.
Researchers found high rates of dyslipidemia and abnormal HbA1c, including 2 cases of diabetes, after screening for cardiovascular risk factors in middle school students.
Canagliflozin reduced the risk for heart failure in the context of both reduced EF and preserved EF.
Real-world data indicate that lower risk of heart failure hospitalization and death associated with use of sodium-glucose cotransporter-2 inhibitors is consistent in patients with T2D with both reduced and preserved ejection fraction.
Clinics in the United States varied widely in their adherence to statin recommendations, which was associated with wide differences in low-density lipoprotein cholesterol control.
Liraglutide and semaglutide demonstrated cardiorenal efficacy regardless of diabetes duration.
Remote blood pressure monitoring by a smartphone app effectively reduces systolic blood pressure at 6 weeks.
Oral preparations of hormone replacement therapy for the treatment of menopausal symptoms are associated with a greater risk for VTE compared with transdermal formulations.